NP
TMO icon

NorthRock Partners’s Thermo Fisher Scientific TMO Stock Holding History

NorthRock Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1,000K Sell
1,994
-661
-25% -$317K 0.01% 305
2026
Q1 		$1.31M Buy
2,655
+175
+7% +$95K 0.02% 255
2025
Q4 		$1.44M Sell
2,480
-3,747
-60% -$2.12M 0.02% 229
2025
Q3 		$3.02M Buy
6,227
+2,080
+50% +$968K 0.05% 153
2025
Q2 		$1.68M Sell
4,147
-369
-8% -$154K 0.04% 152
2025
Q1 		$2.25M Buy
4,516
+60
+1% +$32.5K 0.08% 111
2024
Q4 		$2.32M Sell
4,456
-1,615
-27% -$888K 0.08% 107
2024
Q3 		$3.76M Buy
6,071
+1,163
+24% +$688K 0.12% 82
2024
Q2 		$2.72M Buy
4,908
+702
+17% +$402K 0.1% 95
2024
Q1 		$2.45M Buy
4,206
+533
+15% +$299K 0.09% 106
2023
Q4 		$1.95M Buy
3,673
+928
+34% +$449K 0.08% 117
2023
Q3 		$1.39M Buy
2,745
+131
+5% +$69.8K 0.15% 75
2023
Q2 		$1.36M Sell
2,614
-66
-2% -$35.6K 0.15% 66
2023
Q1 		$1.54M Buy
2,680
+27
+1% +$15.2K 0.16% 60
2022
Q4 		$1.46M Sell
2,653
-1,267
-32% -$671K 0.17% 67
2022
Q3 		$1.99M Sell
3,920
-104
-3% -$58.2K 0.23% 45
2022
Q2 		$2.19M Buy
4,024
+2,276
+130% +$1.25M 0.23% 45
2022
Q1 		$1.03M Sell
1,748
-455
-21% -$261K 0.09% 99
2021
Q4 		$1.47M Buy
2,203
+848
+63% +$529K 0.11% 75
2021
Q3 		$817K Sell
1,355
-70
-5% -$38.4K 0.07% 108
2021
Q2 		$719K Buy
1,425
+152
+12% +$71.7K 0.06% 107
2021
Q1 		$581K Buy
1,273
+42
+3% +$20K 0.05% 113
2020
Q4 		$573K Buy
1,231
+497
+68% +$233K 0.06% 119
2020
Q3 		$324K Buy
+734
New +$303K 0.04% 154

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NorthRock Partners's TMO Position: Q2 2026 in Review

NorthRock Partners reduced its Thermo Fisher Scientific (TMO) stake by 25% in Q2 2026, selling an estimated $317K and leaving 1,994 shares worth $1,000K. The position accounts for 0.01% of the portfolio, ranked #305.

NorthRock Partners first reported a position in TMO in Q3 2020 and has held it in 24 quarters since. The position peaked at $3.76M in Q3 2024. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • NorthRock Partners held 1,994 shares of Thermo Fisher Scientific worth $1,000K as of Q2 2026.
  • NorthRock Partners sold 661 Thermo Fisher Scientific shares in Q2 2026, an estimated $317K.
  • Thermo Fisher Scientific made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #305 holding.
  • NorthRock Partners first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 24 quarters since.
  • NorthRock Partners's Thermo Fisher Scientific position peaked at $3.76M in Q3 2024.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.